Department of Pharmaceutical Chemistry, Government College of Pharmacy, Karad, Maharashtra, 415124, India.
AAPS PharmSciTech. 2012 Jun;13(2):448-59. doi: 10.1208/s12249-012-9760-0. Epub 2012 Mar 2.
Gliclazide (GLI), a poorly water-soluble antidiabetic, was transformed into a glassy state by melt quench technique in order to improve its physicochemical properties. Chemical stability of GLI during formation of glass was assessed by monitoring thin-layer chromatography, and an existence of amorphous form was confirmed by differential scanning calorimetry and X-ray powder diffractometry. The glass transition occurred at 67.5°C. The amorphous material thus generated was examined for its in vitro dissolution performance in phosphate buffer (pH 6.8). Surprisingly, amorphous GLI did not perform well and was unable to improve the dissolution characteristics compared to pure drug over entire period of dissolution studies. These unexpected results might be due to the formation of a cohesive supercooled liquid state and structural relaxation of amorphous form toward the supercooled liquid region which indicated functional inability of amorphous GLI from stability point of view. Hence, stabilization of amorphous GLI was attempted by elevation of T(g) via formation of solid dispersion systems involving comprehensive antiplasticizing as well as surface adsorption mechanisms. The binary and ternary amorphous dispersions prepared with polyvinylpyrrolidone K30 (as antiplasticizer for elevation of T (g)) and Aerosil 200® and/or Sylysia® 350 (as adsorbent) in the ratio of 1:1:1 (w/w) using kneading and spray-drying techniques demonstrated significant enhancement in rate and extent of dissolution of drug initially. During accelerated stability studies, ternary systems showed no significant reduction in drug dissolution performance over a period of 3 months indicating excellent stabilization of amorphous GLI.
格列齐特(GLI)是一种水溶性较差的抗糖尿病药物,通过熔融淬火技术将其转化为玻璃态,以改善其物理化学性质。通过监测薄层色谱法评估 GLI 在形成玻璃过程中的化学稳定性,并通过差示扫描量热法和 X 射线粉末衍射法确认存在无定形形式。玻璃化转变发生在 67.5°C。因此,对生成的无定形材料进行了在磷酸盐缓冲液(pH 6.8)中的体外溶解性能研究。令人惊讶的是,与纯药物相比,无定形 GLI 在整个溶解研究期间并不能改善其溶解特性。这些意外的结果可能是由于形成了有凝聚力的过冷液体状态和无定形形式向过冷液体区域的结构松弛,这表明从稳定性的角度来看,无定形 GLI 的功能丧失。因此,通过形成涉及全面抗塑化以及表面吸附机制的固体分散系统来提高 T(g),尝试稳定无定形 GLI。使用 kneading 和喷雾干燥技术以 1:1:1(w/w)的比例制备的包含聚乙烯吡咯烷酮 K30(作为提高 T(g)的抗塑化剂)和 Aerosil 200®和/或 Sylysia®350(作为吸附剂)的二元和三元无定形分散体在初始时显著提高了药物的溶解速率和程度。在加速稳定性研究中,三元系统在 3 个月的时间内没有显示出药物溶解性能的显著降低,表明无定形 GLI 得到了很好的稳定。